SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001601830-24-000142
Filing Date
2024-08-28
Accepted
2024-08-28 16:49:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A a8-kxaugust282024.htm DEFA14A 32831
2 EX-10.1 exhibit101-agreement.htm EX-10.1 79882
  Complete submission text file 0001601830-24-000142.txt   113856
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40323 | Film No.: 241256197
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)